Can partner counseling cut STI rates in teens?

NCT ID NCT03275168

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether a couples-based counseling program could help young people (ages 16-25) and their partners prevent STIs and HIV. The program added joint health education sessions to existing individual prevention counseling. Researchers enrolled 68 participants from the Baltimore area to see if the approach was feasible and acceptable. The study focused on recruitment and retention, not on whether infections actually dropped.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dyadic counseling and support for condom negotiation

What this could lead to

If successful, this approach could offer a practical way to help young couples reduce their risk of STIs and HIV through better communication and condom use.

What could go wrong

This is a small pilot study with only 68 participants, so results may not apply to everyone. It tests feasibility, not effectiveness, so it's too early to know if it actually prevents infections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXPOSURE TO SEXUALLY TRANSMISSIBLE DISORDER (EVENT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target sexually transmitted disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins Medicine

    Baltimore, Maryland, 21287, United States